Eastgate Biotech Corp.
ETBI · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $5 | $79 | $9 | -$50 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $29 | $868 | $0 | $0 |
| Inventory | $113 | -$868 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $168 | $947 | $9 | -$50 |
| Property Plant & Equip (Net) | $702 | $845 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $800 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $1,502 | $845 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,670 | $1,792 | $9 | $0 |
| Liabilities | – | – | – | – |
| Payables | $654 | $462 | $424 | $280 |
| Short-Term Debt | $2,702 | $2,360 | $1,775 | $1,676 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $95 | $93 | $93 |
| Other Curr. Liab. | $2,620 | $4,782 | $2,101 | -$10 |
| Total Curr. Liab. | $6,961 | $5,816 | $4,894 | $4,578 |
| LT Debt | $0 | $0 | $0 | $40 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | -$40 |
| Total NC Liab. | $0 | $0 | $40 | $40 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $377 | $24 | $50 | $50 |
| Total Liabilities | $6,961 | $5,816 | $4,934 | $4,618 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $11 | $11 | $3 | $3 |
| Retained Earnings | -$18,399 | -$16,298 | -$15,583 | -$14,631 |
| AOCI | -$121 | $58 | $29 | $40 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | -$5,291 | -$4,024 | -$4,925 | -$4,618 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,670 | $1,792 | $9 | $0 |
| Net Debt | $2,697 | $2,282 | $1,766 | $1,767 |